MRSO

MRSO EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of MRSO (5619.T) as of Oct 22, 2026 is -34.14 M JPY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 162.19 M JPY — a change of -121.05% (lower).

EBITDA

-34.14 MJPY

YoY

-121.05%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of MRSO is 2025 -34.14 M JPY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of MRSO was 2024 162.19 M JPY. It decreases by -121.05% lower compared to the previous year.

The MRSO EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2021
887.17 M JPY
Jan 1, 2022
999.62 M JPY
Jan 1, 2023
623.53 M JPY
Jan 1, 2024
162.19 M JPY
Jan 1, 2025
-34.14 M JPY
The MRSO EBITDA history
YEAREBITDAYoY
-34.14 MJPY-121.05%
162.19 MJPY-73.99%
623.53 MJPY-37.62%
999.62 MJPY+12.68%
887.17 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MRSO Stock analysis

What does MRSO do? MRSO Inc generates revenue through comprehensive healthcare platform services including HCPF, which operates MRSO.jp for medical checkup reservations. The company offers DX services for medical facilities featuring MRSO-Plus, a cloud-based reservation management system, and DX services for government with solutions like MRSO Jumin Kenshin, MRSO Vaccine, MRSO Form, and MRSO Go Yoyaku. Large-scale vaccination services provide an online reservation system for vaccinations. Medical facilities and government entities are the primary buyers of these services, utilizing MRSO-Plus for operational efficiency and government systems for public health initiatives. MRSO.jp serves as the core platform for medical checkup reservations, while MRSO Vaccine and MRSO Go Yoyaku target specific vaccination needs. The company’s DX services for medical facilities focus on improving marketing activities and operational efficiency through cloud-based solutions. Government clients purchase systems such as MRSO Jumin Kenshin for resident health checkups and MRSO Form for administrative processes, enhancing public health management. Revenue streams are derived from subscription models for MRSO-Plus, MRSO Vaccine, and other platform services. Medical facilities pay for MRSO-Plus to manage reservations and improve patient engagement, while government agencies invest in MRSO Jumin Kenshin and MRSO Form for large-scale health programs. The vaccination reservation system is a key product for both public health campaigns and routine medical services. MRSO is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MRSO stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of MRSO is -34.14 M JPY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of MRSO changed from 162.19 M JPY to -34.14 M JPY, representing a -121.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) MRSO since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s MRSO historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — MRSO

All Key Metrics — MRSO